Abstract:Introduction: In this study we assessed the contribution of psychopathology, including the two domains of negative symptoms (motivational deficit and expressive deficit), processing speed as an index of neurocognition, and emotion recognition, as an index of social cognition, to poor functional outcomes in people with schizophrenia. Methods: The Positive and Negative Syndrome Scale was used to evaluate positive symptoms and disorganization and the Brief Negative Symptom Scale to assess negative symptoms. The Symbol Coding and the Trail Making Test A and B were used to rate processing speed and the Facial Emotion Identification Test to assess emotion recognition. Functional outcome was assessed with the Personal and Social Performance Scale (PSP). Regression analyses were performed to identify predictors of functional outcome. Mediation analyses was used to investigate whether social cognition and negative symptom domains fully or partially mediated the impact of processing speed on functional outcome. Results: One hundred and fifty subjects from 8 different European centers were recruited. Our data showed that the expressive deficit predicted global functioning and together with motivational deficit fully mediated the effects of neurocognition on it. Motivational deficit was a predictor of personal and social functioning and fully mediated neurocognitive impairment effects on the same outcome. Both motivational deficit and neurocognitive impairment predicted socially useful activities, and the emotion recognition domain of social cognition partially mediated the impact of neurocognitive deficits on this outcome. Conclusions: Our results indicate that pathways to functional outcomes are specific for different domains of real-life functioning and that negative symptoms and social cognition mediate the impact of neurocognitive deficits on different domains of functioning. Our results suggest that both negative symptoms and social cognition should be targeted by psychosocial interventions to enhance the functional impact of neurocognitive remediation.

Negative symptoms in the clinical high‐risk state for psychosis: Connection with cognition and primacy in impacting functioning

Relationship Between Negative Symptoms and Neurocognitive Functions in Adolescent and Adult Patients with First-Episode Schizophrenia

Negative self‐reference as a component of subthreshold psychotic symptoms in clinical high‐risk youth

Relationship of negative symptom severity with cognitive symptoms and functioning in subjects at ultra‐high risk for psychosis

Negative Symptom Trajectories in Individuals at Clinical High Risk for Psychosis: Differences Based on Deficit Syndrome, Persistence, and Transition Status

Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia

The impact of early factors on persistent negative symptoms in youth at clinical high risk for psychosis

Cerebellar-Prefrontal Connectivity Predicts Negative Symptom Severity Across the Psychosis Spectrum

Neuropsychological deficits in participants at clinical high risk for psychosis recruited from the community: relationships to functioning and clinical symptoms

Predictors of functioning in treatment-resistant schizophrenia: the role of negative symptoms and neurocognition

Symptom Dimensions and Cognitive Impairments in Individuals at Clinical High Risk for Psychosis

The Role of Two Factors of Negative Symptoms and Cognition on Social Functioning in Male Patients with Schizophrenia: A Mediator Model.

Negative symptoms and concomitant attention deficits in schizophrenia: Associations with prospective assessments of anxiety, social dysfunction, and avoidant coping

Metacognitive deficits predict future levels of negative symptoms in schizophrenia controlling for neurocognition, affect recognition, and self-expectation of goal attainment

Neural correlates of positive and negative symptoms through the illness course: an fMRI study in early psychosis and chronic schizophrenia

Association of negative symptoms with cognitive impairment in Chinese Han patients with chronic schizophrenia

Overlap between individual differences in cognition and symptoms of schizophrenia

Evidence of Discontinuity Between Psychosis-Risk and Non-Clinical Samples in the Neuroanatomical Correlates of Social Function.

Cognitive Impairment and Diminished Neural Responses Constitute a Biomarker Signature of Negative Symptoms in Psychosis

Sex- and Age-Specific Deviations in Cerebellar Structure and Their Link With Symptom Dimensions and Clinical Outcome in Individuals at Clinical High Risk for Psychosis

Negative Symptoms and Their Associations with Other Clinical Variables and Working Memory Across the Schizophrenia Spectrum and Bipolar Disorder